ML
CLVS

McAdam LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

McAdam LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,842
Closed -$63K – 173
2020
Q3 		$63K Sell
10,842
-6,690
-38% -$40K 0.01% 139
2020
Q2 		$118K Sell
17,532
-9,883
-36% -$74.8K 0.03% 121
2020
Q1 		$174K Buy
27,415
+12,180
+80% +$97.7K 0.05% 100
2019
Q4 		$159K Buy
15,235
+3,045
+25% +$22.1K 0.04% 85
2019
Q3 		$48K Buy
+12,190
New +$98.6K 0.01% 82

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

McAdam LLC's CLVS Position: Q4 2020 in Review

McAdam LLC sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 10,842 shares — an estimated $63K sold.

McAdam LLC first reported a position in CLVS in Q3 2019 and held it in 5 quarters. The position peaked at $174K in Q1 2020. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

  • McAdam LLC reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
  • McAdam LLC sold 10,842 Clovis Oncology, Inc. shares in Q4 2020, an estimated $63K.
  • McAdam LLC first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 5 quarters.
  • McAdam LLC's Clovis Oncology, Inc. position peaked at $174K in Q1 2020.
  • 159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on McAdam LLC's 13F filing for Q4 2020, filed 12 Jan 2021.